Showing results (491-500 of 700) with videos related to

Sort By:
Pageof 70
Journal of the American Heart Association|April 29, 2023
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD TrialGlenn M Chertow, Ricardo Correa-Rotter, Priya Vart, et al.
Diabetes & Vascular Disease Research|May 22, 2016
Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristicsPeter Godsk Jørgensen, Magnus T Jensen, Rasmus Mogelvang, et al.
Frontiers in Nutrition|February 27, 2023
Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover studyHelena Zander Wodschow, Filip Søskov Davidovski, Jacob Christensen, et al.
Kidney International|November 11, 2022
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetesGeorge L Bakris, Luis M Ruilope, Stefan D Anker, et al.
Diabetes Care|May 25, 2019
Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 DiabetesSigne A Winther, Jens C Øllgaard, Nete Tofte, et al.
Diabetes|January 21, 2022
Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE TrialEmil Wolsk, Mikkel Jürgens, Morten Schou, et al.
Clinical Kidney Journal|February 24, 2023
Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetesJens Christian Laursen, Niels Søndergaard-Heinrich, Bryan Haddock, et al.
BMJ Open|March 20, 2024
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trialsShweta Bansal, Maria E F Canziani, Rita Birne, et al.
Diabetes, Obesity & Metabolism|November 4, 2020
No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE-D trialKim K B Clemmensen, Martin B Blond, Hanan Amadid, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 5, 2014
Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathyJustyna Siwy, Joost P Schanstra, Angel Argiles, et al.
Pageof 70